Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030

The global biosurgery market is projected to reach USD 21.59 million by 2030 from USD 15.83 million in 2025, at a CAGR of 6.4% during the forecast period.The biosurgery market is experiencing robust growth, propelled by several key dynamics. A primary driver is the increasing prevalence of chronic conditions that necessitate surgical interventions, alongside a rise in severe traumatic injuries. As these incidents become more common, there is a corresponding uptick in the volume of elective surgical procedures, subsequently fueling the demand for biosurgical products. Moreover, the escalating need for efficient blood loss management and the enhanced availability of advanced biosurgical technologies further support market expansion. However, this growth trajectory faces challenges, including the high cost associated with biosurgery products, a shortage of adequately skilled professionals, and a stringent regulatory environment, all of which are anticipated to hinder the market's progress over the forecast period.

The demineralized bone matrix subsegment, by bone graft substitutes, held the largest market share in 2024.

Based on product, the biosurgery market is divided into bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple-line reinforcement agents. In 2024, the bone graft substitute market was predominantly led by the demineralized bone matrix (DBM) segment, which is recognized for its dual osteoconductive and osteoinductive properties, thereby facilitating effective bone regeneration. Within the broader category of bone graft substitutes—which includes synthetic grafts, bone morphogenetic proteins (BMPs), and other alternatives—DBM has emerged as the most significant player in the biosurgery sector. DBM is extensively employed in various orthopedic procedures, such as spinal fusion and hip & knee replacements, owing to its enhanced clinical efficacy in promoting bone healing. Its versatility is further accentuated by its availability in multiple forms, including pastes, putty, sheets, and flexible fragments, allowing for tailored surgical applications. The process of creating DBM involves the removal of inorganic minerals from allograft bones, which unveils BMPs that actively stimulate osteogenesis. This characteristic positions DBM as a reliable and biologically active substitute for autografts. Furthermore, implementing terminal sterilization techniques, such as gamma irradiation and electron-beam sterilization, ensures the safety and integrity of the product. The sustained preference of surgeons for DBM as a safe, effective, and accessible graft substitute continues to reinforce its leading status within this market segment.

The ambulatory surgical centers of the biosurgery end user market are expected to command the highest CAGR during the study period.

The biosurgery market, based on end users, is divided into ambulatory surgical centers (ASCs), hospitals, clinics, and other end users. The ambulatory surgical centers (ASCs) segment is anticipated to lead growth in the biosurgery market throughout the forecast period. This expansion is underpinned by an increasing demand for cost-effective, efficient, and minimally invasive surgical options. ASCs present an economically viable alternative to traditional hospitals while upholding high standards for surgical safety and clinical outcomes, making them increasingly appealing to patients and healthcare practitioners. These centers are optimally equipped to perform various outpatient procedures, including orthopedic, ophthalmic, cosmetic, and general surgeries. In these settings, biosurgical products such as sealants, hemostats, and adhesion barriers are critical in enhancing surgical precision and promoting patient recovery. Advancements in surgical techniques, anesthesia, and biosurgical technologies accelerate the ongoing transition of surgical volumes from inpatient environments to outpatient facilities. Factors such as rising healthcare expenditures, advantageous reimbursement policies for outpatient procedures, and reduced patient recovery times are further driving the growth of ASCs. As patient preferences increasingly lean toward expedited, same-day procedures with a minimized risk of hospital-acquired infections, the demand for biosurgical solutions in ASCs is projected to escalate, thus propelling rapid growth in this segment.

In 2024, the North America region accounted for the largest share in the biosurgery market.

The global biosurgery market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, the North American region is projected to maintain the largest share of the global biosurgery market, attributable to its sophisticated healthcare infrastructure, elevated surgical rates, and the concentration of prominent industry players. This region has experienced notable increases in cosmetic and reconstructive surgeries and a marked rise in orthopedic procedures. According to Discovery ABA, approximately 26.2 million surgical and minimally invasive cosmetic and reconstructive procedures were performed in the United States in 2022, reflecting a 19% increase in cosmetic surgeries compared to 2019. Furthermore, the 2022 data from the American Joint Replacement Registry (AJRR) highlights over 2.8 million hip and knee procedures conducted across all 50 states and the District of Columbia, underscoring the significant demand for biosurgery products in joint replacement and orthopedic applications. Key drivers for this market expansion include a growing geriatric population, a high incidence of chronic diseases, and an increasing volume of surgical interventions necessitating advanced hemostatic agents, sealants, and materials for soft tissue repair. Coupled with favorable reimbursement frameworks, heightened patient awareness, and substantial R&D investments from leading companies such as Johnson & Johnson, Baxter, and Stryker, North America is solidifying its position as the most dominant and mature biosurgery market globally.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1- 40%, Tier 2- 30%, and Tier 3- 30%
• By Designation: C-level- 50%, Director level- 30%, and Others- 20%
• By Region: North America- 30%, Europe- 25%, Asia Pacific- 20%, Latin America- 15%, and Middle East & Africa- 10%.

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.0 billion, Tier 2 = USD 1.0 billion to USD 10.0 billion, and Tier 3 =
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the biosurgery market include Johnson & Johnson Services, Inc. (US), Baxter (US), Medtronic (Ireland), Becton, Dickinson and Company (BD) (US), B. Braun Melsungen AG (Germany), Stryker (US), Integra Lifesciences Holdings Corporation (US),CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Artivion Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), Smiths & Nephew PLC (UK), Tissue Regenix (UK), Betatech Medical (Turkey), Meril Lifesciences Pvt. Ltd. (India), RTI Surgicals (US), Samyang Holdings Corp. (South Korea), Aroa Biosurgery Ltd. (New Zealand), Meyer-Haake GmbH (Germany), Advanced Medical Solutions Group PLC (UK), BioCer Entwicklungs-GmbH(Germany), and Hannox International Corp. (Taiwan)

Research Coverage

This report studies the biosurgery market based on product, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments concerning five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:

• Analysis of key drivers (increasing volume of surgeries and growing prevalence of severe trauma injuries, strong focus on R&D leading to launch of technologically advanced products, and rising need for effective blood loss management in patients), restraints (high price of biosurgery products and rising cost of surgical procedures), opportunities (increasing use of combination materials for enhancing product efficacy, rising adoption of advanced biosurgery products in emerging markets, and growing adoption of adhesive dentistry procedures), challenges (stringent regulatory framework and requirement of skilled personnel for the effective use of biosurgery products)
• Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the biosurgery market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, R&D initiatives, and product launches within the biosurgery market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the biosurgery industry help to diversify the market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Johnson & Johnson Services, Inc. (US), Baxter (US), Medtronic (Ireland), Becton Dickinson and Company (BD) (US), B. Braun SE (Germany), Stryker (US), Integra LifeSciences Holdings Corporation (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Artivion Inc. (US), and others.

Show more

Tables List

Table 1 Biosurgery Market: Inclusions & Exclusions

Table 2 Standard Currency Conversion Rates

Table 3 Biosurgery Market: Study Assumptions

Table 4 Biosurgery Market: Risk Analysis

Table 5 Import Data For Hs Code 300610, By Country,

2019–2024 (Usd Thousand)

Table 6 Export Data For Hs Code 300610, By Country,

2019–2024 (Usd Thousand)

Table 7 Biosurgery Market: Porter’s Five Forces

Table 8 Influence Of Stakeholders On Buying Process Of Top Three Biosurgery Products

Table 9 Key Buying Criteria For Biosurgery Products

Table 10 North America: Regulatory Bodies, Government Agencies, And Other Organizations

Table 11 Europe: Regulatory Bodies, Government Agencies, And Other Organizations

Table 12 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations

Table 13 Latin America: Regulatory Bodies, Government Agencies, And Other Organizations

Table 14 Middle East & Africa: Regulatory Bodies, Government Agencies, And Other Organizations

Table 15 Average Selling Price Trend Of Biosurgery Products, By Key Player, 2022–2024 (Usd)

Table 16 Average Selling Price Trend Of Biosurgery Products, By Region,

2022–2024 (Usd)

Table 17 Biosurgery Market: Detailed List Of Key Conferences & Events,

January 2025–december 2026

Table 18 Biosurgery Market: Unmet Needs/End-user Expectations

Table 19 Us-adjusted Reciprocal Tariff Rates

Table 20 Key Product-related Tariff Effective For Biosurgery Products

Table 21 Biosurgery Market, By Country, 2023–2030 (Usd Million)

Table 22 Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 23 Biosurgery Market For Bone-graft Substitutes, By Country,

2023–2030 (Usd Million)

Table 24 Major Demineralized Bone Matrix Products Available In Market

Table 25 Demineralized Bone Matrix Market, By Country,

2023–2030 (Usd Million)

Table 26 Major Synthetic Bone Grafts Available In Market

Table 27 Synthetic Bone Grafts Market, By Country, 2023–2030 (Usd Million)

Table 28 Major Bone Morphogenetic Proteins Available In Market

Table 29 Bone Morphogenetic Proteins Market, By Country,

2023–2030 (Usd Million)

Table 30 Other Bone-graft Substitutes Market, By Country,

2023–2030 (Usd Million)

Table 31 Biosurgery Market For Surgical Sealants & Adhesives, By Type,

2023–2030 (Usd Million)

Table 32 Biosurgery Market For Surgical Sealants & Adhesives, By Country, 2023–2030 (Usd Million)

Table 33 Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 34 Natural/Biological Surgical Sealants & Adhesives Market, By Country, 2023–2030 (Usd Million)

Table 35 Major Fibrin-based Sealants & Adhesives Available In Market

Table 36 Fibrin-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 37 Major Collagen Based-sealants & Adhesives Available In Market

Table 38 Collegen-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 39 Major Gelatin Based-sealants & Adhesives Available In Market

Table 40 Gelatin-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 41 Major Albumin Based-sealants & Adhesives Available In Market

Table 42 Albumin-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 43 Other Natural/Biological Surgical Sealants & Adhesives Market,

By Country, 2023–2030 (Usd Million)

Table 44 Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 45 Animal-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 46 Human Blood-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 47 Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 48 Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market,

By Country, 2023–2030 (Usd Million)

Table 49 Major Products Peg Hydrogel-based Sealants & Adhesives Available In Market

Table 50 Peg Hyrogel-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 51 Major Cyanoacrylate-based Sealants & Adhesives Available In Market

Table 52 Cyanoacrylate-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 53 Urethane-based Sealants & Adhesives Market, By Country,

2023–2030 (Usd Million)

Table 54 Other Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Country, 2023–2030 (Usd Million)

Table 55 Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 56 Biosurgery Market For Adhesion Barriers, By Country,

2023–2030 (Usd Million)

Table 57 Synthetic Adhesion Barriers Market, By Type, 2023–2030 (Usd Million)

Table 58 Synthetic Adhesion Barriers Market, By Country,

2023–2030 (Usd Million)

Table 59 Major Hyaluronic Acid-based Adhesion Barriers Available In Market

Table 60 Hyaluronic Acid-based Adhesion Barriers Market, By Country,

2023–2030 (Usd Million)

Table 61 Major Regenerated Cellulose-based Adhesion Barriers Available In Market

Table 62 Regenerated Cellulose -based Adhesion Barriers Market, By Country, 2023–2030 (Usd Million)

Table 63 Major Peg-based Adhesion Barriers Available In Market

Table 64 Peg-based Adhesion Barriers Market, By Country,

2023–2030 (Usd Million)

Table 65 Other Synthetic Adhesion Barriers Market, By Country,

2023–2030 (Usd Million)

Table 66 Natural Adhesion Barriers Market, By Type, 2023–2030 (Usd Million)

Table 67 Major Collagen & Protein Adhesion Barriers Available In Market

Table 68 Collagen & Protein Adhesion Barriers Market, By Country,

2023–2030 (Usd Million)

Table 69 Major Fibrin-based Adhesion Barriers Available In Market

Table 70 Fibrin-based Adhesion Barriers Market, By Country,

2023–2030 (Usd Million)

Table 71 Major Staple-line Reinforcement Agents Available In Market

Table 72 Biosurgery Market For Staple-line Reinforcement Agents, By Country, 2023–2030 (Usd Million)

Table 73 Biosurgery Market For Soft-tissue Attchments, By Type,

2023–2030 (Usd Million)

Table 74 Biosurgery Market For Soft-tissue Attchments, By Country,

2023–2030 (Usd Million)

Table 75 Major Synthetic Meshes Available In Market

Table 76 Synthetic Meshes Market, By Country, 2023–2030 (Usd Million)

Table 77 Major Biological Meshes Available In Market

Table 78 Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 79 Biological Meshes Market, By Country, 2023–2030 (Usd Million)

Table 80 Allografts Market, By Country, 2023–2030 (Usd Million)

Table 81 Xenografts Market, By Country, 2023–2030 (Usd Million)

Table 82 Major Hemostatic Agents Available In Market

Table 83 Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 84 Biosurgery Market For Hemostatic Agents, By Country,

2023–2030 (Usd Million)

Table 85 Major Thrombin-based Hemostatic Agents Available In Market

Table 86 Thrombin-based Hemostatic Agents Market, By Country,

2023–2030 (Usd Million)

Table 87 Major Oxidized Regenerated Cellulose-based Hemostatic Agents Available In Market

Table 88 Oxidized Regenerated Cellulose-based Hemostatic Agents Market,

By Country, 2023–2030 (Usd Million)

Table 89 Major Combination Hemostatic Agents Available In Market

Table 90 Combination Hemostatic Agents Market, By Country,

2023–2030 (Usd Million)

Table 91 Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 92 Biosurgery Market For Orthopedic Surgery, By Country,

2023–2030 (Usd Million)

Table 93 Biosurgery Market For General Surgery, By Country,

2023–2030 (Usd Million)

Table 94 Biosurgery Market For Neurological Surgery, By Country,

2023–2030 (Usd Million)

Table 95 Biosurgery Market For Cardiovascular Surgery, By Country,

2023–2030 (Usd Million)

Table 96 Biosurgery Market For Reconstructive Surgery, By Country,

2023–2030 (Usd Million)

Table 97 Biosurgery Market For Gynecological Surgery, By Country,

2023–2030 (Usd Million)

Table 98 Biosurgery Market For Urological Surgery, By Country,

2023–2030 (Usd Million)

Table 99 Biosurgery Market For Thoracic Surgery, By Country,

2023–2030 (Usd Million)

Table 100 Biosurgery Market For Other Applications, By Country,

2023–2030 (Usd Million)

Table 101 Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 102 Biosurgery Market For Hospitals, By Country, 2023–2030 (Usd Million)

Table 103 Biosurgery Market For Clinics, By Country, 2023–2030 (Usd Million)

Table 104 Biosurgery Market For Ambulatory Surgical Centers, By Country, 2023–2030 (Usd Million)

Table 105 Biosurgery Market For Other End Users, By Country,

2023–2030 (Usd Million)

Table 106 Biosurgery Market, By Region, 2023–2030 (Usd Million)

Table 107 North America: Biosurgery Market, By Country,

2023–2030 (Usd Million)

Table 108 North America: Biosurgery Market, By Product,

2023–2030 (Usd Million)

Table 109 North America: Biosurgery Market For Bone-graft Substitutes,

By Type, 2023–2030 (Usd Million)

Table 110 North America: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 111 North America: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 112 North America: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 113 North America: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 114 North America: Biosurgery Market For Adhesion Barriers, By Type, 2023–2030 (Usd Million)

Table 115 North America: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 116 North America: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 117 North America: Biosurgery Market For Soft-tissue Attachments,

By Type, 2023–2030 (Usd Million)

Table 118 North America: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 119 North America: Biosurgery Market For Hemostatic Agents, By Type, 2023–2030 (Usd Million)

Table 120 North America: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 121 North America: Biosurgery Market, By End User,

2023–2030 (Usd Million)

Table 122 Us: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 123 Us: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 124 Us: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 125 Us: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 126 Us: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 127 Us: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 128 Us: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 129 Us: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 130 Us: Natural Adhesion Barriers Market, By Type, 2023–2030 (Usd Million)

Table 131 Us: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 132 Us: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 133 Us: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 134 Us: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 135 Us: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 136 Canada: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 137 Canada: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 138 Canada: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 139 Canada: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 140 Canada: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 141 Canada: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 142 Canada: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 143 Canada: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 144 Canada: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 145 Canada: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 146 Canada: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 147 Canada: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 148 Canada: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 149 Canada: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 150 Europe: Biosurgery Market, By Country, 2023–2030 (Usd Million)

Table 151 Europe: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 152 Europe: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 153 Europe: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 154 Europe: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 155 Europe: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 156 Europe: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 157 Europe: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 158 Europe: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 159 Europe: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 160 Europe: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 161 Europe: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 162 Europe: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 163 Europe: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 164 Europe: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 165 Germany: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 166 Germany: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 167 Germany: Biosurgery Market For Surgical Sealants & Adhesives,

By Type, 2023–2030 (Usd Million)

Table 168 Germany: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 169 Germany: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 170 Germany: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 171 Germany: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 172 Germany: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 173 Germany: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 174 Germany: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 175 Germany: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 176 Germany: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 177 Germany: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 178 Germany: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 179 Uk: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 180 Uk: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 181 Uk: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 182 Uk: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 183 Uk: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 184 Uk: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 185 Uk: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 186 Uk: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 187 Uk: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 188 Uk: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 189 Uk: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 190 Uk: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 191 Uk: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 192 Uk: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 193 France: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 194 France: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 195 France: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 196 France: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 197 France: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 198 France: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 199 France: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 200 France: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 201 France: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 202 France: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 203 France: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 204 France: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 205 France: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 206 France: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 207 Italy: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 208 Italy: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 209 Italy: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 210 Italy: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 211 Italy: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 212 Italy: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 213 Italy: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 214 Italy: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 215 Italy: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 216 Italy: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 217 Italy: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 218 Italy: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 219 Italy: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 220 Italy: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 221 Spain: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 222 Spain: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 223 Spain: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 224 Spain: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 225 Spain: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 226 Spain: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 227 Spain: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 228 Spain: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 229 Spain: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 230 Spain: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 231 Spain: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 232 Spain: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 233 Spain: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 234 Spain: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 235 Rest Of Europe: Biosurgery Market, By Product,

2023–2030 (Usd Million)

Table 236 Rest Of Europe: Biosurgery Market For Bone-graft Substitutes,

By Type, 2023–2030 (Usd Million)

Table 237 Rest Of Europe: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 238 Rest Of Europe: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 239 Rest Of Europe: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 240 Rest Of Europe: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 241 Rest Of Europe: Biosurgery Market For Adhesion Barriers, By Type, 2023–2030 (Usd Million)

Table 242 Rest Of Europe: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 243 Rest Of Europe: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 244 Rest Of Europe: Biosurgery Market For Soft-tissue Attachments,

By Type, 2023–2030 (Usd Million)

Table 245 Rest Of Europe: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 246 Rest Of Europe: Biosurgery Market For Hemostatic Agents, By Type, 2023–2030 (Usd Million)

Table 247 Rest Of Europe: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 248 Rest Of Europe: Biosurgery Market, By End User,

2023–2030 (Usd Million)

Table 249 Asia Pacific: Biosurgery Market, By Country, 2023–2030 (Usd Million)

Table 250 Asia Pacific: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 251 Asia Pacific: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 252 Asia Pacific: Biosurgery Market For Surgical Sealants & Adhesives,

By Type, 2023–2030 (Usd Million)

Table 253 Asia Pacific: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 254 Asia Pacific: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 255 Asia Pacific: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 256 Asia Pacific: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 257 Asia Pacific: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 258 Asia Pacific: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 259 Asia Pacific: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 260 Asia Pacific: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 261 Asia Pacific: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 262 Asia Pacific: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 263 Asia Pacific: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 264 China: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 265 China: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 266 China: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 267 China: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 268 China: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 269 China: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 270 China: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 271 China: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 272 China: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 273 China: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 274 China: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 275 China: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 276 China: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 277 China: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 278 India: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 279 India: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 280 India: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 281 India: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 282 India: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 283 India: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 284 India: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 285 India: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 286 India: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 287 India: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 288 India: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 289 India: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 290 India: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 291 India: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 292 Japan: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 293 Japan: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 294 Japan: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 295 Japan: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 296 Japan: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 297 Japan: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 298 Japan: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 299 Japan: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 300 Japan: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 301 Japan: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 302 Japan: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 303 Japan: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 304 Japan: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 305 Japan: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 306 South Korea: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 307 South Korea: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 308 South Korea: Biosurgery Market For Surgical Sealants & Adhesives,

By Type, 2023–2030 (Usd Million)

Table 309 South Korea: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 310 South Korea: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 311 South Korea: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 312 South Korea: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 313 South Korea: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 314 South Korea: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 315 South Korea: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 316 South Korea: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 317 South Korea: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 318 South Korea: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 319 South Korea: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 320 Australia: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 321 Australia: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 322 Australia: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 323 Australia: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 324 Australia: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 325 Australia: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Us d Million)

Table 326 Australia: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 327 Australia: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 328 Australia: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 329 Australia: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 330 Australia: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 331 Australia: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 332 Australia: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 333 Australia: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 334 Rest Of Asia Pacific: Biosurgery Market, By Product,

2023–2030 (Usd Million)

Table 335 Rest Of Asia Pacific: Biosurgery Market For Bone-graft Substitutes,

By Type, 2023–2030 (Usd Million)

Table 336 Rest Of Asia Pacific: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 337 Rest Of Asia Pacific: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 338 Rest Of Asia Pacific: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 339 Rest Of Asia Pacific: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 340 Rest Of Asia Pacific: Biosurgery Market For Adhesion Barriers, By Type, 2023–2030 (Usd Million)

Table 341 Rest Of Asia Pacific: Synthetic Adhesion Barriers Market, By Type, 2023–2030 (Usd Million)

Table 342 Rest Of Asia Pacific: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 343 Rest Of Asia Pacific: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 344 Rest Of Asia Pacific: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 345 Rest Of Asia Pacific: Biosurgery Market For Hemostatic Agents, By Type, 2023–2030 (Usd Million)

Table 346 Rest Of Asia Pacific: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 347 Rest Of Asia Pacific: Biosurgery Market, By End User,

2023–2030 (Usd Million)

Table 348 Latin America: Biosurgery Market, By Country, 2023–2030 (Usd Million)

Table 349 Latin America: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 350 Latin America: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 351 Latin America: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 352 Latin America: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 353 Latin America: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 354 Latin America: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 355 Latin America: Biosurgery Market For Adhesion Barriers, By Type, 2023–2030 (Usd Million)

Table 356 Latin America: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 357 Latin America: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 358 Latin America: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 359 Latin America: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 360 Latin America: Biosurgery Market For Hemostatic Agents, By Type, 2023–2030 (Usd Million)

Table 361 Latin America: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 362 Latin America: Biosurgery Market, By End User,

2023–2030 (Usd Million)

Table 363 Brazil: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 364 Brazil: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 365 Brazil: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 366 Brazil: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 367 Brazil: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 368 Brazil: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 369 Brazil: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 370 Brazil: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 371 Brazil: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 372 Brazil: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 373 Brazil: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 374 Brazil: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 375 Brazil: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 376 Brazil: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 377 Mexico: Biosurgery Market, By Product, 2023–2030 (Usd Million)

Table 378 Mexico: Biosurgery Market For Bone-graft Substitutes, By Type,

2023–2030 (Usd Million)

Table 379 Mexico: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 380 Mexico: Natural/Biological Surgical Sealants & Adhesives Market,

By Type, 2023–2030 (Usd Million)

Table 381 Mexico: Natural/Biological Surgical Sealants & Adhesives Market,

By Origin, 2023–2030 (Usd Million)

Table 382 Mexico: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 383 Mexico: Biosurgery Market For Adhesion Barriers, By Type,

2023–2030 (Usd Million)

Table 384 Mexico: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 385 Mexico: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 386 Mexico: Biosurgery Market For Soft-tissue Attachments, By Type,

2023–2030 (Usd Million)

Table 387 Mexico: Biological Meshes Market, By Type, 2023–2030 (Usd Million)

Table 388 Mexico: Biosurgery Market For Hemostatic Agents, By Type,

2023–2030 (Usd Million)

Table 389 Mexico: Biosurgery Market, By Application, 2023–2030 (Usd Million)

Table 390 Mexico: Biosurgery Market, By End User, 2023–2030 (Usd Million)

Table 391 Rest Of Latin America: Biosurgery Market, By Product,

2023–2030 (Usd Million)

Table 392 Rest Of Latin America: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 393 Rest Of Latin America: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 394 Rest Of Latin America: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 395 Rest Of Latin America: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 396 Rest Of Latin America: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 397 Rest Of Latin America: Biosurgery Market For Adhesion Barriers,

By Type, 2023–2030 (Usd Million)

Table 398 Rest Of Latin America: Synthetic Adhesion Barriers Market, By Type, 2023–2030 (Usd Million)

Table 399 Rest Of Latin America: Natural Adhesion Barriers Market, By Type, 2023–2030 (Usd Million)

Table 400 Rest Of Latin America: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 401 Rest Of Latin America: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 402 Rest Of Latin America: Biosurgery Market For Hemostatic Agents,

By Type, 2023–2030 (Usd Million)

Table 403 Rest Of Latin America: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 404 Rest Of Latin America: Biosurgery Market, By End User,

2023–2030 (Usd Million)

Table 405 Middle East & Africa: Biosurgery Market, By Region,

2023–2030 (Usd Million)

Table 406 Middle East & Africa: Biosurgery Market, By Product,

2023–2030 (Usd Million)

Table 407 Middle East & Africa: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 408 Middle East & Africa: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 409 Middle East & Africa: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 410 Middle East & Africa: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 411 Middle East & Africa: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 412 Middle East & Africa: Biosurgery Market For Adhesion Barriers,

By Type, 2023–2030 (Usd Million)

Table 413 Middle East & Africa: Synthetic Adhesion Barriers Market, By Type, 2023–2030 (Usd Million)

Table 414 Middle East & Africa: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 415 Middle East & Africa: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 416 Middle East & Africa: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 417 Middle East & Africa: Biosurgery Market For Hemostatic Agents,

By Type, 2023–2030 (Usd Million)

Table 418 Middle East & Africa: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 419 Middle East & Africa: Biosurgery Market, By End User,

2023–2030 (Usd Million)

Table 420 Gcc Countries: Biosurgery Market, By Product,

2023–2030 (Usd Million)

Table 421 Gcc Countries: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 422 Gcc Countries: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 423 Gcc Countries: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 424 Gcc Countries: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 425 Gcc Countries: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 426 Gcc Countries: Biosurgery Market For Adhesion Barriers, By Type, 2023–2030 (Usd Million)

Table 427 Gcc Countries: Synthetic Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 428 Gcc Countries: Natural Adhesion Barriers Market, By Type,

2023–2030 (Usd Million)

Table 429 Gcc Countries: Biosurgery Market For Soft-tissue Attachments,

By Type, 2023–2030 (Usd Million)

Table 430 Gcc Countries: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 431 Gcc Countries: Biosurgery Market For Hemostatic Agents, By Type, 2023–2030 (Usd Million)

Table 432 Gcc Countries: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 433 Gcc Countries: Biosurgery Market, By End User,

2023–2030 (Usd Million)

Table 434 Rest Of Middle East & Africa: Biosurgery Market, By Product,

2023–2030 (Usd Million)

Table 435 Rest Of Middle East & Africa: Biosurgery Market For Bone-graft Substitutes, By Type, 2023–2030 (Usd Million)

Table 436 Rest Of Middle East & Africa: Biosurgery Market For Surgical Sealants & Adhesives, By Type, 2023–2030 (Usd Million)

Table 437 Rest Of Middle East & Africa: Natural/Biological Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 438 Rest Of Middle East & Africa: Natural/Biological Surgical Sealants & Adhesives Market, By Origin, 2023–2030 (Usd Million)

Table 439 Rest Of Middle East & Africa: Synthetic & Semi-synthetic Surgical Sealants & Adhesives Market, By Type, 2023–2030 (Usd Million)

Table 440 Rest Of Middle East & Africa: Biosurgery Market For Adhesion Barriers, By Type, 2023–2030 (Usd Million)

Table 441 Rest Of Middle East & Africa: Synthetic Adhesion Barriers Market,

By Type, 2023–2030 (Usd Million)

Table 442 Rest Of Middle East & Africa: Natural Adhesion Barriers Market,

By Type, 2023–2030 (Usd Million)

Table 443 Rest Of Middle East & Africa: Biosurgery Market For Soft-tissue Attachments, By Type, 2023–2030 (Usd Million)

Table 444 Rest Of Middle East & Africa: Biological Meshes Market, By Type,

2023–2030 (Usd Million)

Table 445 Rest Of Middle East & Africa: Biosurgery Market For Hemostatic Agents, By Type, 2023–2030 (Usd Million)

Table 446 Rest Of Middle East & Africa: Biosurgery Market, By Application,

2023–2030 (Usd Million)

Table 447 Rest Of Middle East & Africa: Biosurgery Market, By End User,

2023–2030 (Usd Million)

Table 448 Overview Of Strategies Deployed By Key Players In Biosurgery Market

Table 449 Biosurgery Market: Degree Of Competition

Table 450 Biosurgery Market: Region Footprint

Table 451 Biosurgery Market: Product Footprint

Table 452 Biosurgery Market: Application Footprint

Table 453 Biosurgery Market: End-user Footprint

Table 454 Biosurgery Market: Detailed List Of Key Startups/Sme Players

Table 455 Biosurgery Market: Competitive Benchmarking Of Key

Startups/Sme Players, By Product And Region

Table 456 Biosurgery Market: Product Launches & Approvals,

January 2022–june 2025

Table 457 Biosurgery Market: Deals, January 2022–june 2025

Table 458 Baxter: Company Overview

Table 459 Baxter: Products Offered

Table 460 B Braun Se: Company Overview

Table 461 B Braun Se: Products Offered

Table 462 Becton, Dickinson And Company (Bd): Company Overview

Table 463 Becton, Dickinson And Company (Bd): Products Offered

Table 464 Johnson & Johnson: Company Overview

Table 465 Johnson & Johnson: Products Offered

Table 466 Medtronic: Company Overview

Table 467 Medtronic: Products Offered

Table 468 Integra Lifesciences Corporation: Company Overview

Table 469 Integra Lifesciences Corporation: Products Offered

Table 470 Commonwealth Serum Laboratories Limited (Csl): Company Overview

Table 471 Commonwealth Serum Laboratories Limited (Csl): Products Offered

Table 472 Hemostasis, Llc: Company Overview

Table 473 Hemostasis, Llc: Products Offered

Table 474 Pfizer Inc.: Company Overview

Table 475 Pfizer Inc.: Products Offered

Table 476 Stryker: Company Overview

Table 477 Stryker: Products Offered

Table 478 Artivion, Inc.: Company Overview

Table 479 Artivion, Inc.: Products Offered

Table 480 Zimmer Biomet: Company Overview

Table 481 Zimmer Biomet: Products Offered

Table 482 Zimmer Biomet: Deals, January 2022–june 2025

Table 483 Kuros Biosciences: Company Overview

Table 484 Kuros Biosciences: Products Offered

Table 485 Kuros Biosciences: Product Approvals, January 2021–june 2025

Table 486 Kuros Biosciences: Deals, January 2022–june 2025

Table 487 Orthofix Medical Inc.: Company Overview

Table 488 Orthofix Medical Inc.: Products Offered

Table 489 Orthofix Medical Inc.: Product Launches, January 2021–june 2025

Table 490 Orthofix Medical Inc.: Deals, January 2022–june 2025

Table 491 Smith & Nephew: Company Overview

Table 492 Smith & Nephew: Products Offered

Table 493 Tissue Regenix: Company Overview

Table 494 Betatech Medical: Company Overview

Table 495 Meril Life Sciences Pvt. Ltd.: Company Overview

Table 496 Globus Medical: Company Overview

Table 497 Samyang Holdings Corporation: Company Overview

Table 498 Aroa Biosurgery Limited: Company Overview

Table 499 Meyer-haake Gmbh: Company Overview

Table 500 Advanced Medical Solutions Group Plc: Company Overview

Table 501 Biocer Entwicklungs-gmbh: Company Overview

Table 502 Wiltrom: Company Overview

Figures List

Figure 1 Biosurgery Market Segmentation & Regional Scope

Figure 2 Biosurgery Market: Years Considered

Figure 3 Biosurgery Market: Research Design

Figure 4 Biosurgery Market: Key Data From Secondary Sources

Figure 5 Biosurgery Market: Key Primary Sources (Demand And Supply Sides)

Figure 6 Biosurgery Market: Key Data From Primary Sources

Figure 7 Biosurgery Market: Key Industry Insights

Figure 8 Breakdown Of Primary Interviews: By Company Type, Designation, And Region

Figure 9 Biosurgery Market Size Estimation (Revenue Share Analysis)

Figure 10 Biosurgery Market: Top-down Approach

Figure 11 Impact Analysis Of Drivers, Restraints, Opportunities,

And Challenges (2025–2030)

Figure 12 Biosurgery Market: Cagr Projections

Figure 13 Biosurgery Market: Data Triangulation Methodology

Figure 14 Biosurgery Market, By Product, 2025 Vs. 2030 (Usd Million)

Figure 15 Biosurgery Market, By Application, 2025 Vs. 2030 (Usd Million)

Figure 16 Biosurgery Market, By End User, 2025 Vs. 2030 (Usd Million)

Figure 17 Biosurgery Market: Regional Snapshot

Figure 18 Rising Surgical Volumes And Increasing Focus On Medical Tourism To Drive Market

Figure 19 Us And Hospitals Segment Commanded Largest North American Market Share In 2024

Figure 20 India To Witness Highest Cagr During Study Period

Figure 21 Asia Pacific To Register Highest Growth Rate From 2025 To 2030

Figure 22 Emerging Markets To Register Higher Growth Rates During Forecast Period

Figure 23 Biosurgery Market: Drivers, Restraints, Opportunities, And Challenges

Figure 24 Biosurgery Market: Value Chain Analysis

Figure 25 Biosurgery Market: Ecosystem Analysis

Figure 26 Biosurgery Market: Supply Chain Analysis

Figure 27 Biosurgery Market: Porter’s Five Forces Analysis

Figure 28 Influence Of Key Stakeholders On Buying Process

Of Top Three Biosurgery Products

Figure 29 Key Buying Criteria For Biosurgery Products

Figure 30 Canada: Class Iii Medical Device Approval Process

Figure 31 Top 10 Companies With Highest Number Of Patents Applied/Published (January 2014–june 2025)

Figure 32 Top Applicant Countries/Regions For Biosurgery Patents

(January 2014− May 2025)

Figure 33 Adjacent Market Analysis: Adhesion Barriers Market (Market Overview)

Figure 34 Biosurgery Market: Trends/Disruptions Impacting Customer’s Business

Figure 35 Biosurgery Market: Funding And Number Of Deals,

2019–2023 (Usd Million)

Figure 36 Key Features Of Ai/Gen Ai In Biosurgery Market

Figure 37 Biosurgery Market: Geographic Snapshot

Figure 38 North America: Biosurgery Market Snapshot

Figure 39 Asia Pacific: Biosurgery Market Snapshot

Figure 40 Revenue Analysis Of Key Players In Biosurgery Market (2020–2024)

Figure 41 Market Share Analysis Of Key Players In Biosurgery Market (2024)

Figure 42 Biosurgery Market: Company Evaluation Matrix (Key Players), 2024

Figure 43 Biosurgery Market: Company Footprint

Figure 44 Biosurgery Market: Company Evaluation Matrix (Startups/Smes), 2024

Figure 45 Ev/Ebitda Of Key Vendors

Figure 46 Year-to-date (Ytd) Price Total Return And 5-year Stock

Beta Of Key Vendors

Figure 47 Biosurgery Market: Brand/Product Comparative Analysis

Figure 48 Baxter: Company Snapshot

Figure 49 B Braun Se: Company Snapshot

Figure 50 Becton, Dickinson And Company (Bd): Company Snapshot

Figure 51 Johnson & Johnson: Company Snapshot

Figure 52 Medtronic: Company Snapshot

Figure 53 Integra Lifesciences Corporation: Company Snapshot

Figure 54 Commonwealth Serum Laboratories Limited (Csl): Company Snapshot

Figure 55 Pfizer Inc.: Company Snapshot

Figure 56 Stryker: Company Snapshot

Figure 57 Artivion, Inc.: Company Snapshot

Figure 58 Zimmer Biomet: Company Snapshot

Figure 59 Kuros Biosciences: Company Snapshot

Figure 60 Orthofix Medical Inc.: Company Snapshot

Figure 61 Smith & Nephew: Company Snapshot